Source: BMC Urology. Unidade: FMRP
Subjects: NEOPLASIAS PROSTÁTICAS, BIOMARCADORES, IMUNOHISTOQUÍMICA, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OUELLET, Véronique et al. The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation. BMC Urology, v. 18, 2018Tradução . . Disponível em: https://doi.org/10.1186/s12894-018-0392-x. Acesso em: 19 nov. 2024.APA
Ouellet, V., Aprikian, A., Bergeron, A., Brimo, F., Bristow, R. G., Chevalier, S., et al. (2018). The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation. BMC Urology, 18. doi:10.1186/s12894-018-0392-xNLM
Ouellet V, Aprikian A, Bergeron A, Brimo F, Bristow RG, Chevalier S, Drachenberg D, Fazli L, Fleshner NE, Gleave M, Karakiewicz P, Klotz L, Lacombe L, Lattouf J-B, Kwast T van der, Squire JA, Latour M, Trudel D, Mes-Masson A-M, Saad F. The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation [Internet]. BMC Urology. 2018 ; 18[citado 2024 nov. 19 ] Available from: https://doi.org/10.1186/s12894-018-0392-xVancouver
Ouellet V, Aprikian A, Bergeron A, Brimo F, Bristow RG, Chevalier S, Drachenberg D, Fazli L, Fleshner NE, Gleave M, Karakiewicz P, Klotz L, Lacombe L, Lattouf J-B, Kwast T van der, Squire JA, Latour M, Trudel D, Mes-Masson A-M, Saad F. The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation [Internet]. BMC Urology. 2018 ; 18[citado 2024 nov. 19 ] Available from: https://doi.org/10.1186/s12894-018-0392-x
